Flunixin Injection

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

ingredients actius:

Flunixin meglumine

Disponible des:

Norbrook Laboratories (Ireland) Limited

Codi ATC:

QM01AG90

Designació comuna internacional (DCI):

Flunixin meglumine

Dosis:

50 milligram(s)/millilitre

formulario farmacéutico:

Solution for injection

tipo de receta:

POM: Prescription Only Medicine as defined in relevant national legislation

Área terapéutica:

flunixin

Estat d'Autorització:

Authorised

Data d'autorització:

1997-04-23

Fitxa tècnica

1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Flunixin Injection, 50mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Flunixin (as flunixin meglumine)
50 mg
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
QUANTITATIVE COMPOSITION IF THAT INFORMATION IS
ESSENTIAL
FOR
PROPER
ADMINISTRATION
OF
THE
VETERINARY MEDICINAL PRODUCT
Phenol
5.0 mg
Sodium Formaldehyde Sulphoxylate Dihydrate
2.5 mg
Disodium Edetate
Sodium Hydroxide
Propylene Glycol
Hydrochloric Acid
Water for Injections
A clear colourless solution for injection.
3 CLINICAL INFORMATION
3.1 TARGET SPECIES
Cattle, horses and pigs.
3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES
The veterinary medicinal product is indicated for use in cattle and
horses in the alleviation of
inflammation and pain.
In the horse, the veterinary medicinal product is indicated for the
alleviation of inflammatory
signs associated with musculo-skeletal disorders and for the
alleviation of visceral pain
associated with colic.
In cattle, the veterinary medicinal product is indicated for the
control of acute inflammation
associated with respiratory disease. The veterinary medicinal product
has also been shown
to have some benefit in the treatment of acute pulmonary emphysema
(fog fever) and as
adjunctive therapy in the treatment of acute mastitis.
In pigs, the veterinary medicinal product is indicated as an
adjunctive therapy in the
treatment of swine respiratory diseases.
3.3 CONTRAINDICATIONS
Do not exceed the recommended dose or duration of treatment. Do not
administer to
pregnant mares.
Use is contraindicated in animals suffering from cardiac, hepatic or
renal disease, where there
is the possibility of gastro-intestinal ulceration or bleeding, where
there is evidence of a
blood dyscrasia or hypersensitivity to the product.
3.4 SPECIAL WARNINGS
The cause of the underlying inflammatory condition or colic should be
determined and
treated with appropriate concomitant therapy.
3.5 SPECIAL PRECAUTIONS FOR USE
Spe